首页 | 本学科首页   官方微博 | 高级检索  
检索        

病毒性脑炎患儿NSE、S100B蛋白和神经肽Y水平变化的研究
引用本文:汤卫红,江雪娟,王惠庭,姚泽忠.病毒性脑炎患儿NSE、S100B蛋白和神经肽Y水平变化的研究[J].中国医师杂志,2010,12(4):477-479.
作者姓名:汤卫红  江雪娟  王惠庭  姚泽忠
作者单位:1. 温州医学院附属台州医院路桥院区,浙江省台州,318050
2. 恩泽母子医院
摘    要:目的 探讨病毒性脑炎患儿血清及脑脊液神经元特异性烯醇化酶(NSE)、S100B蛋白和神经肽Y(NPY)的水平变化及临床意义.方法 检测50例病毒性脑炎患儿(重症20例,轻症30例)及选择同期住院20例凝诊病毒性脑炎儿行腰穿排除中枢神经系统感染者(对照组)的血清和脑脊液NSE、S100B蛋白和NPY水平,并进行对比分析.结果 病毒性脑炎组血清和脑脊液NSE、S100B蛋白和NPY的含量血清:(18.90±5.50)μg/L,(0.57±0.26)μg/L,(267.3±54.7)μg/L;GSF:(10.45±4.40)μg/L,(0.93±0.53)μg/L,(347.2±60.6)μg/L]均高于对照组血清:(10.35±2.49)μg/L,(10±0.06)μg/L,(67.8±22.5)μg/L;GSF:(3.96±1.57)μg/L,(0.29±0.18)μg/L,(102.6±38.9)μg/L](P<0.01),重症组血清和脑脊液NSE、S100B蛋白和NPY的含量血清:(21.93±5.39)μg/L,(0.71±0.31)μg/L,(32.5±62.8)μg/L;GSF:(13.05±4.41)μg/L,(1.23±0.66)μg/L,(407.3±68.1)μg/L]均高于轻症组血清:(15.93±4.02)μg/L,(0.42±0.14)μg/L,(234.7±51.2)μg/L;GSF:(8.05±1.77)μg/L,(0.63±0.26)μg/L,(320.2±59.5)μg/L](P〈0.01).结论 NSE、S100B蛋白和NPY的检测有助于判断儿童病毒性脑炎的病情和脑损伤程度,可作为评估预后的重要生化指标.

关 键 词:脑炎  病毒生/代谢  磷酸丙酮酸水合酶/代谢  S100蛋白质类/代谢  神经肽Y/代谢

Study on the changes of NSE, S100B protein and NPY levels in children with viral encephalitis
TANG Wei-hong,JIANG Xue-juan,WANG Hui-ting,YAO Ze-zhong.Study on the changes of NSE, S100B protein and NPY levels in children with viral encephalitis[J].Journal of Chinese Physician,2010,12(4):477-479.
Authors:TANG Wei-hong  JIANG Xue-juan  WANG Hui-ting  YAO Ze-zhong
Institution:. ( The Taizhou Luqiao Review Hospital Affiliated to Wenzhou Medical College, Taizhou 318050, China)
Abstract:Objective To study the changes of neuron-specific-enolase (NSE), S100B protein and neuropeptide Y (NPY) levels in serum and cerebrospinal fluid of children with viral encephalitis and their clinical significance. Methods The NSE, S100B protein and NPY levels in the serum and cerebrospinal fluid of 50 children with viral encephalitiswere were measured, and another 20 children without central nervous system infection were selected as controls. Results The NSE, S100B protein and NPY levels in the serum and cerebrospinal fluid of children with viral encephalitisserum: (18.90 ± 5. 50)μg/L, (0. 57 ±0. 26) μg/L, (267. 3 ± 54. 7 ) μg/L; GSF: ( 10. 45 ± 4. 40) μg/L, (0. 93 ± 0. 53 ) μg/L, (347.2 ± 60. 6) μg/L] were higher than those in control group serum: ( 10. 35 ± 2. 49 ) μg/L, ( 10 ± 0. 06 ) μg/L, ( 67. 8 ±22.5)μg/L;GSF:(3.96 ± 1.57)μg/L,(0. 29 ±0. 18)μg/L,(102.6 ±38.9) μg/L] ( P <0.01). The levels of serum and CSF NSE S100B protein and NPY in critical patientserum: (21.93 ±5.39)μg/L,(0.71 ±0. 31)μg/L, (32. 5 ± 62. 8) μg/L;GSF: (13.05 ±4.41)μg/L, (1.23 ± 0. 66) μg/L, (407.3 ±68. 1 ) μg/L] were higher than ordinary patients serum: ( 15.93 ± 4. 02 ) μg/L, ( 0. 42 ± 0. 14 ) μg/L,(234.7 ±51.2)μ.g/L;GSF:(8.05 ± 1.77) μg/L,(0. 63 ±0.26)μg/L, (320.2 ±59.5) μg/L] ( P <0. 01 ). Conclusion NSE, S100B protein and NPY can be used to evaluate encephalitis condition, brain damage degree and prognosis of viral encephalitis.
Keywords:Encephalitis  Viral/ME  Phosphopyruvate hydratase/ME  S100 proteins/ME  Neuropeptide Y/ME
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号